News Releases

Archive

Canadians turn to self-care during the COVID-19 pandemic and want more support and information to continue managing their health in the future

July 20, 2020 – In a recent survey, Canadians were asked about the management of their health before and during the COVID-19 pandemic, including their self-care activities and viewpoints. Self-care is the ability of individuals, families, and communities to promote health, prevent disease, maintain health, and cope with illness and disability with or without the support of a healthcare provider. Approximately half of survey respondents have missed an in-person appointment with a doctor due to the COVID-19 pandemic response measures. Read More >

Déclaration de PSC Canada sur le traitement du COVID-19 à la famotidine

La famotidine sert à traiter les brulements d’estomac et les indigestions en réduisant la production d’acide gastrique. Bien que la famotidine en association avec un médicament antiviral soit présentement au stade initial d’étude comme traitement potentiel du coronavirus dans certains hôpitaux new-yorkais, rien ne démontre que ces produits traitent le COVID-19.

Produits de santé consommateurs Canada (PSC Canada) conseille aux Canadiens qui ont des questions à propos de la pandémie de COVID-19 sur la façon de se prémunir contre le virus de faire confiance aux professionnels, Read More >

CHP Canada Statement on treating COVID-19 with Famotidine

Famotidine is used to treat heartburn/indigestion by decreasing stomach acid production. While famotidine in combination with an anti-viral drug is under initial study as a potential coronavirus treatment in some New York hospitals, these products have not been demonstrated to treat COVID-19.

Consumer Health Products Canada (CHP Canada) advises Canadians who have questions on the COVID-19 pandemic and on how they can protect themselves from the virus, to rely on health professionals, Read More >

CHP Canada Reminds Canadians of the Risks of Accidental Ingestion during the COVID-19 Pandemic

The current COVID-19 pandemic means that Canadian families, especially children, are spending a lot more time at home. Keeping our homes safe and clean has never been more important. As a result, many of us are buying, using and storing more cleaning products, over-the-counter medicines and hand sanitizers than we would normally.  

With this in mind, Consumer Health Products Canada (CHP Canada) reminds Canadians of a few useful principles about using, Read More >

PSC Canada rappelle aux Canadiens les risques reliés à l’ingestion accidentelle au cours de la pandémie de COVID-19

La pandémie de COVID-19 qui bat son plein signifie que les familles canadiennes, et surtout les enfants, passent beaucoup plus de temps à la maison. La sécurité et la propreté de nos maisons n’ont jamais été aussi importantes. Ainsi, plusieurs d’entre vous achetez, utilisez et conservez davantage de produits de nettoyage, de médicaments sans ordonnance et de désinfectant pour les mains qu’à la normale.

Ceci étant dit, Produits de santé consommateurs Canada (PSC Canada) rappelle aux Canadiens quelques principes utiles à propos de l’usage, Read More >

CHP Canada Statement on the Role of Nicotine in COVID-19 Infection

Nicotine replacement therapies such as gums, patches, lozenges, and sprays are clinically proven to support smokers trying to break free from tobacco use. These products should not, however, be used to protect against COVID-19. Nicotine has not been tested against any strains of coronavirus and these products are not intended to prevent or treat COVID-19.

Consumer Health Products Canada (CHP Canada) advises Canadians who have questions on the COVID-19 pandemic and on how they can protect themselves from the virus, Read More >

Déclaration de PSC Canada concernant le rôle de la nicotine dans l’infection au COVID-19

Les thérapies de remplacement de la nicotine comme les gommes à mâcher, les timbres, les pastilles et les vaporisateurs sont des moyens cliniquement éprouvés de soutenir les fumeurs qui tentent de se libérer du tabagisme. Ces produits ne doivent en aucun cas servir à vous protéger du COVID-19. La nicotine n’a fait l’objet d’aucun essai contre quelque souche de coronavirus que ce soit et ces produits ne sont conçus ni pour prévenir, ni pour traiter le COVID-19. Read More >

CHP Canada Statement on using NSAIDs to treat COVID-19 symptoms

Consumer Health Products Canada (CHP Canada) advises all Canadians who have questions about pain and fever management during the COVID-19 pandemic to rely on health professionals, public health officials, government-run health portals, and approved product labels.

The recent debate about a link between the use of non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and poorer COVID-19 outcomes is not based on clinical evidence, as Health Canada has now also stated. Read More >

Déclaration de PSC Canada à propos de l’usage des AINS pour le traitement des symptômes de la maladie du COVID-19

Produits de santé consommateurs Canada (PSC Canada) informe tous les Canadiens qui ont des questions à propos du traitement de la douleur et de la fièvre pendant la pandémie de la maladie du COVID-19 de se fier aux professionnels de la santé, aux autorités de santé publique, aux portails de santé gouvernementaux et aux étiquettes de produits approuvés.

Le récent débat à propos du supposé lien entre l’utilisation de médicaments anti-inflammatoires non stéroïdes (AINS) comme l’ibuprofène et des résultats défavorables face au COVID-19 n’est pas fondé sur des preuves scientifiques, Read More >

Plus de 800 000 Canadiens font l’expérience du cannabis récréatif ou illégal à des fins de santé.

Le 21 novembre 2019 (Ottawa, ON) – Selon Statistique Canada, quelque 811 000 Canadiens utilisent des produits de cannabis récréatif ou illicite à des fins de santé et ce, sans avis ni ordonnance du médecin. Ces produits ne sont pas approuvés par Santé Canada à titre de médicaments en vente libre ou de produits de santé naturelle. Tant que Santé Canada n’aura pas modifié la loi qui empêche les fabricants de médicaments en vente libre et de produits de santé naturelle de demander leur approbation, Read More >

Over 800,000 Canadians are experimenting with recreational or illegal cannabis products for their health

21 November 2019 (Ottawa, ON) – According to Statistics Canada, there are 811,000 Canadians taking recreational or illegal cannabis products for their health without a doctor note/prescription. These are not products that have been approved by Health Canada as over-the-counter medicines (OTCs) or natural health products (NHPs). Until Health Canada changes the law that prevents the manufactures of OTCs and NHPs from seeking their approval, they never will be. 

Consumer Health Products Canada recognizes that cannabis is being embraced as a health product globally.  Read More >

International Self-Care Day 2019

July 24, 2019 – Today, we celebrate International Self-Care Day.  This day is a great reminder for each of us as individuals, but also for governments to make self-care a priority.  Self-care is all about the important role you play in your own health.  Whether exercising, brushing your teeth, eating well, applying sunscreen, quitting smoking, or treating fevers and headaches, self-care is what we all do to stay healthy.

Put simply, Read More >

International Self-Care Day – Canadian Campaign Launch

Consumer Health Products Canada (CHP Canada) and International Counterparts Launch Online Campaign to Promote Benefits of Self-Care

July 24, 2018 (OTTAWA, ON) – Self-care is vital to the health of Canadians, has a positive impact on the healthcare system and should be practiced daily. MPs Rob Oliphant and Marilyn Gladu launched International Self-Care Day (ISCD) today, a world-wide initiative led in Canada by Consumer Health Products Canada (CHP Canada). Read More >

Federal/Provincial/Territorial Governments Launch Regulatory Cooperation Initiatives

Consumer Health Products Canada (CHP Canada) applauds move that will improve self-care options for Canadians and reduce healthcare costs.


July 20, 2018 (OTTAWA, ON)
– CHP Canada welcomes the premiers’ commitment today to work toward fixing the inconsistent federal and provincial processes determining conditions of sale for over-the-counter (OTC) medicines. This will give more options to Canadians who practice self-care and will reduce healthcare costs. Read More >

Parliamentary Health Committee Recognizes Importance of Self-Care in Pharmacare Report

OTTAWA (April 19, 2018) – Consumer Health Products Canada (CHP Canada) and its members today welcomed the House of Commons Standing Committee on Health’s recognition of the value of self-care in its national pharmacare report. The report calls on the federal Minister of Health to improve access to new non-prescription or over-the-counter (OTC) drugs for use in self-care by working with her provincial and territorial counterparts to better coordinate their regulation.

“Reducing the delays in access to new medicines for use in self-care can improve overall access to affordable medicines and reduce healthcare costs,” said Karen Proud, Read More >

1 2 3 4

Show 5 - 15 - 25 results per page